Vira Shield 4+VL5 HBThis page contains information on Vira Shield 4+VL5 HB for veterinary use.
The information provided typically includes the following:
- Vira Shield 4+VL5 HB Indications
- Warnings and cautions for Vira Shield 4+VL5 HB
- Direction and dosage information for Vira Shield 4+VL5 HB
Vira Shield 4+VL5 HBThis treatment applies to the following species:
Bovine Rhinotracheitis-Virus Diarrhea Vaccine
Campylobacter Fetus-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin
For Use In Animals Only
Vira Shield 4+VL5 HB Indications
This product has been shown to be effective for the vaccination of healthy cattle against disease caused by infectious bovine rhinotracheitis (IBR), bovine virus diarrhea (BVD Type 1 and BVD Type 2) viruses and Campylobacter fetus, Leptospira canicola, grippotyphosa, hardjo-bovis, icterohaemorrhagiae, and pomona. The duration of immunity against BVD Type 2 is at least 11 months, and C. fetus and L. hardjo-bovis is at least 12 months. The duration of immunity against the remaining antigens in this product has not been established. For more information regarding efficacy and safety data, see productdata.aphis.usda.gov.
The product has been shown to be effective against kidney colonization, urinary shedding, and reproductive tract infection caused by L. hardjo-bovis. Vaccinated animals subsequently exposed to L. borgpetersenii serovar hardjo (type hardjo-bovis) have been shown to clear renal infections within 8 weeks of exposure. Produced from non-cytopathic (BVD Type 1 and BVD Type 2) and cytopathic (BVD Type 1) isolates. This product is safe for use in pregnant cows and heifers.
ADJUVANT: Xtend™ SP.
Directions For Use
Shake well before using. Administer 5 mL subcutaneously 2 to 4 weeks prior to breeding. In accordance with Beef Quality Assurance guidelines, this product should be administered subcutaneously (under the skin) in the neck. Revaccinate in 4 to 5 weeks. Historically, annual revaccination has been recommended for this product. The need for this booster has not been established. For advice on revaccination, contact a veterinarian.
PrecautionsStore out of direct sunlight at 2° to 8°C (35° to 46°F). DO NOT FREEZE. Use entire contents when first opened. Do not mix with other products, except as specified on the label. In case of human exposure, contact a physician. Do not vaccinate within 60 days prior to slaughter. Transient swelling may occur at the site of injection. Milk reduction and transient depression may be observed in lactating dairy cows for 3 to 6 days following vaccination. Anaphylactic reactions may occur. Symptomatic treatment: Epinephrine. Contains amphotericin B, gentamicin, and thimerosal as preservatives.
Elanco US, Inc., Fort Dodge, IA 50501 USA; 1-800-428-4441
Vira Shield, Xtend, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates.
Distributed by ELANCO US, INC.
2500 INNOVATION WAY, GREENFIELD, IN, 46140
|Every effort has been made to ensure the accuracy of the Vira Shield 4+VL5 HB information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.|
Copyright © 2021 Animalytix LLC. Updated: 2021-10-04